NeuroStar is a non-drug, noninvasive treatment that can improve the quality of life for people suffering from neurohealth conditions. NeuroStar is FDA-cleared for adults with major depressive disorder (MDD), as an adjunct for adults with obsessive-compulsive disorder (OCD), and to decrease anxiety symptoms in adult patients with MDD that may exhibit comorbid anxiety symptoms (anxious depression). NeuroStar is the leading TMS treatment for MDD in adults with over 4.5 million treatments delivered and is backed by the largest clinical data set of any TMS system for depression, including the world’s largest depression Outcomes Registry. For safety and prescribing information, www.neurostar.com